Skip to main content
Clinical Trials/NCT00649701
NCT00649701UnknownPhase 1

Phase 1 Online Intervention to Reduce Sexual Risk Among Men Who Have Sex With Men

Public Health Solutions1 site in 1 country3,097 target enrollmentStarted: April 2008Last updated:
Conditions

Trial Snapshot

Phase
Phase 1
Enrollment
3,097
Locations
1
Primary Endpoint
HIV disclosure, HIV testing, and condom use

Study Overview

Brief Summary

The purpose of this study is to develop and test the efficacy of online HIV risk reduction interventions among men who have sex with men.

Detailed Description

This is an Internet-based, five-branch randomized controlled intervention, enrolling 3,000 adult MSM. The five branches include 1) a control condition receiving no intervention content, 2) a standard text-based prevention webpage, 3) an 8 minute dramatic video addressing sexual risk reduction within the context of alcohol use, 4) a 5 minute documentary video addressing HIV disclosure, HIV testing, and condom use with the sub-context of drug use, and 5) both videos. After completing the baseline survey, eligible participants who consent to participate in the intervention will be randomly assigned to the control condition or one of the four intervention conditions. The control condition will not include the delivery of any intervention content. All participants (branches 1-5) will be asked to complete a brief post-intervention survey (to measure intentions). All intervention participants will be invited to complete a final 60-day follow-up survey.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Single (Participant)

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
Male
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • Age 18 and over;
  • Ability to read and respond in English;
  • Reside within the United States;
  • Report oral or anal sex with any male (new partner or not) in the past 60 days AND report oral, anal or vaginal sex for the first time with any partner (male or female) in the past 60 days;
  • Complete baseline survey
  • Provide an email address;

Exclusion Criteria

  • Women and transgender persons

Outcomes

Primary Outcomes

HIV disclosure, HIV testing, and condom use

Time Frame: 60 days

Secondary Outcomes

  • drug and/or alcohol use before sex, and depressive and/or anxiety symptomatology (past 2 weeks)(60 days)

Investigators

Sponsor Class
Other

Study Sites (1)

Loading locations...

Similar Trials